Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C095284 |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17179207
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]] | affects binding|decreases reaction|increases reaction | 17179207
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17179207
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of PPARGC1A mRNA | decreases expression | 20406850
|
C457499 |
2-chloro-5-nitrobenzanilide |
2-chloro-5-nitrobenzanilide inhibits the reaction [alitretinoin results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 16513826
|
C457499 |
2-chloro-5-nitrobenzanilide |
2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 16513826
|
C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17116659
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein] | affects binding|decreases reaction | 16889744
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PPARGC1A mRNA | affects expression | 17562736
|
D000242 |
Cyclic AMP |
Cyclic AMP promotes the reaction [PPARGC1A protein binds to CYP2A5 promoter] | affects binding|increases reaction | 18602936
|
D000242 |
Cyclic AMP |
Cyclic AMP results in increased expression of PPARGC1A mRNA | increases expression | 18602936
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PPARGC1A protein | affects expression | 20106945
|
C430898 |
AGN 194204 |
AGN 194204 results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
D000420 |
Albuterol |
Albuterol results in increased expression of PPARGC1A mRNA | increases expression | 17446185
|
D000450 |
Aldosterone |
Aldosterone results in increased expression of PPARGC1A mRNA | increases expression | 19808358
|
D000450 |
Aldosterone |
[Aldosterone binds to NR3C2 protein] which binds to PPARGC1A protein alternative form | affects binding | 15761029
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
C103303 |
alitretinoin |
2-chloro-5-nitrobenzanilide inhibits the reaction [alitretinoin results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 16513826
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
C103303 |
alitretinoin |
PPARG protein promotes the reaction [alitretinoin results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
C103303 |
alitretinoin |
RXRA protein promotes the reaction [alitretinoin results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PPARGC1A mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of PPARGC1A mRNA | increases expression | 20458559
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of PPARGC1A mRNA | affects expression | 17331233
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PPARGC1A mRNA | decreases expression | 20106945
|
D001629 |
Bezafibrate |
Bezafibrate results in increased expression of PPARGC1A mRNA | increases expression | 17275789
|
D020122 |
tert-Butylhydroperoxide |
PPARGC1A protein results in decreased susceptibility to tert-Butylhydroperoxide | decreases response to substance | 17460188
|
D020122 |
tert-Butylhydroperoxide |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17116659
|
D020122 |
tert-Butylhydroperoxide |
SB 203580 inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17116659
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PPARGC1A protein | increases expression | 17116659
|
D020122 |
tert-Butylhydroperoxide |
tyrphostin AG 1478 inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17116659
|
D002248 |
Carbon Monoxide |
Carbon Monoxide results in increased expression of PPARGC1A mRNA | increases expression | 17179207
|
D002248 |
Carbon Monoxide |
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17179207
|
D002248 |
Carbon Monoxide |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]] | affects binding|decreases reaction|increases reaction | 17179207
|
D002248 |
Carbon Monoxide |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17179207
|
D002248 |
Carbon Monoxide |
Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein] | affects binding|increases reaction | 17179207
|
D002248 |
Carbon Monoxide |
Carbon Monoxide results in increased expression of PPARGC1A protein | increases expression | 17179207
|
D002791 |
Cholesterol, Dietary |
Cholesterol, Dietary results in increased expression of PPARGC1A mRNA | increases expression | 19509184
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 19509184
|
C039671 |
ciglitazone |
ciglitazone results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
C039671 |
ciglitazone |
PPARG protein promotes the reaction [ciglitazone results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
D002976 |
Clenbuterol |
Clenbuterol results in increased expression of PPARGC1A mRNA | increases expression | 17446185
|
D002976 |
Clenbuterol |
Propranolol inhibits the reaction [Clenbuterol results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 17446185
|
D002976 |
Clenbuterol |
Clenbuterol results in increased expression of PPARGC1A mRNA | increases expression | 17446185
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PPARGC1A mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of PPARGC1A mRNA | increases expression | 19022236
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of PPARGC1A mRNA | increases expression | 18972406
|
D003907 |
Dexamethasone |
INS protein inhibits the reaction [Dexamethasone results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 18972406
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 19509184
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of PPARGC1A mRNA | decreases expression | 18457598
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of PPARGC1A mRNA | increases expression | 18042831
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [VDR protein binds to PPARGC1A protein] | affects binding|increases reaction | 15908514
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 17404688
|
D000431 |
Ethanol |
Ethanol results in increased expression of PPARGC1A mRNA | increases expression | 16098508
|
D005576 |
Forskolin |
Forskolin results in increased expression of PPARGC1A mRNA | increases expression | 16357189
|
D005632 |
Fructose |
Fructose results in decreased expression of PPARGC1A mRNA | decreases expression | 18063403
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 19509184
|
D005632 |
Fructose |
Fructose results in increased expression of PPARGC1A mRNA | increases expression | 19196556
|
D005632 |
Fructose |
Fructose results in increased expression of PPARGC1A protein | increases expression | 19196556
|
D005632 |
Fructose |
rosiglitazone inhibits the reaction [Fructose results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 19196556
|
D005947 |
Glucose |
Glucose deficiency results in decreased expression of PPARGC1A mRNA | decreases expression | 17855661
|
D005947 |
Glucose |
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA] | decreases expression|decreases reaction | 17855661
|
C425931 |
GW 501516 |
[GW 501516 co-treated with PPARD protein] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 17275789
|
C425931 |
GW 501516 |
GW 501516 results in increased expression of PPARGC1A mRNA | increases expression | 17275789
|
C056599 |
icariin |
icariin results in increased expression of PPARGC1A mRNA | increases expression | 17883938
|
C056599 |
icariin |
icariin results in increased expression of PPARGC1A protein | increases expression | 17883938
|
C026777 |
ICI 118551 |
ICI 118551 results in decreased expression of PPARGC1A mRNA | decreases expression | 17446185
|
D007545 |
Isoproterenol |
Isoproterenol results in increased expression of PPARGC1A mRNA | increases expression | 19808358
|
C006552 |
kaempferol |
kaempferol results in increased expression of PPARGC1A mRNA | increases expression | 17327447
|
C082161 |
lipopolysaccharide A |
lipopolysaccharide A results in decreased expression of PPARGC1A mRNA | decreases expression | 16061943
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of PPARGC1A mRNA | decreases expression | 16847310
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 16513826
|
D009599 |
Nitroprusside |
Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of PPARGC1A mRNA] | decreases expression|decreases reaction | 17855661
|
D009638 |
Norepinephrine |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 16513826
|
D009638 |
Norepinephrine |
Norepinephrine results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
D009638 |
Norepinephrine |
[Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | affects cotreatment|decreases reaction|increases expression | 16513826
|
D009638 |
Norepinephrine |
Norepinephrine inhibits the reaction [Testosterone results in decreased expression of PPARGC1A mRNA] | decreases expression|decreases reaction | 16954335
|
C041786 |
palm oil |
palm oil results in increased expression of PPARGC1A mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of PPARGC1A mRNA | increases expression | 19270015
|
D010833 |
Phytic Acid |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 18657603
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPARGC1A mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid promotes the reaction [PPARGC1B protein results in decreased expression of PPARGC1A mRNA] | decreases expression|increases reaction | 17932310
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PPARGC1A mRNA | increases expression | 18445702 17275789
|
D011224 |
Prazosin |
[Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | affects cotreatment|decreases reaction|increases expression | 16513826
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of PPARGC1A mRNA | increases expression | 17404688
|
D011433 |
Propranolol |
[Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA] | affects cotreatment|decreases reaction|increases expression | 16513826
|
D011433 |
Propranolol |
Propranolol inhibits the reaction [Clenbuterol results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 17446185
|
D011433 |
Propranolol |
Propranolol results in decreased expression of PPARGC1A mRNA | decreases expression | 17446185
|
C031280 |
pyrazole |
pyrazole results in decreased expression of PPARGC1A mRNA | decreases expression | 17945193
|
D011794 |
Quercetin |
Quercetin results in increased expression of PPARGC1A mRNA | increases expression | 19211721
|
D011794 |
Quercetin |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 18657603
|
C059514 |
resveratrol |
resveratrol results in increased expression of PPARGC1A protein | increases expression | 16849586
|
C059514 |
resveratrol |
[resveratrol co-treated with Quercetin co-treated with Phytic Acid] results in increased expression of PPARGC1A mRNA | affects cotreatment|increases expression | 18657603
|
C059514 |
resveratrol |
resveratrol promotes the reaction [SIRT1 protein results in decreased acetylation of PPARGC1A protein] | decreases acetylation|increases reaction | 17581637
|
C059514 |
resveratrol |
resveratrol results in decreased acetylation of and results in increased activity of PPARGC1A protein | decreases acetylation|increases activity | 17112576
|
C059514 |
resveratrol |
resveratrol results in decreased acetylation of PPARGC1A protein | decreases acetylation | 17581637
|
C059514 |
resveratrol |
resveratrol results in increased activity of PPARGC1A protein | increases activity | 17086191
|
C059514 |
resveratrol |
resveratrol results in increased expression of PPARGC1A mRNA | increases expression | 17438283
|
D012293 |
Rifampin |
Rifampin promotes the reaction [PPARGC1A protein binds to CYP2A6 promoter] | affects binding|increases reaction | 16857725
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
C089730 |
rosiglitazone |
2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | decreases reaction|increases expression | 16513826
|
C089730 |
rosiglitazone |
PPARGC1A protein promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
C089730 |
rosiglitazone |
PPARGC1A protein promotes the reaction [rosiglitazone results in increased expression of UCP1 mRNA] | increases expression|increases reaction | 16513826
|
C089730 |
rosiglitazone |
[PPARG protein co-treated with RXRA protein] promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | affects cotreatment|increases expression|increases reaction | 16513826
|
C089730 |
rosiglitazone |
PPARG protein promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of PPARGC1A protein | increases expression | 16513826
|
C089730 |
rosiglitazone |
rosiglitazone inhibits the reaction [Fructose results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 19196556
|
C057823 |
salmeterol |
salmeterol results in increased expression of PPARGC1A mRNA | increases expression | 17446185
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17116659
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of PPARGC1A mRNA | increases expression | 19822182
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [PPARGC1A protein binds to ESRRG protein] | affects binding|decreases reaction | 16889744
|
D013739 |
Testosterone |
Norepinephrine inhibits the reaction [Testosterone results in decreased expression of PPARGC1A mRNA] | decreases expression|decreases reaction | 16954335
|
D013739 |
Testosterone |
Testosterone results in decreased expression of PPARGC1A mRNA | decreases expression | 16954335
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PPARGC1A mRNA | decreases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PPARGC1A mRNA | increases expression | 16840543
|
C057693 |
troglitazone |
PPARG protein promotes the reaction [troglitazone results in increased expression of PPARGC1A mRNA] | increases expression|increases reaction | 16513826
|
C057693 |
troglitazone |
troglitazone results in increased expression of PPARGC1A mRNA | increases expression | 16513826
|
D014425 |
Turpentine |
Turpentine results in decreased expression of PPARGC1A mRNA | decreases expression | 16061943
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PPARGC1A protein] | decreases reaction|increases expression | 17116659
|
D014801 |
Vitamin A |
Vitamin A affects the reaction [PPARGC1A protein binds to PCK1 promoter] | affects binding|affects reaction | 16317119
|
C488234 |
XCT790 |
XCT790 results in decreased expression of PPARGC1A protein | decreases expression | 19464277
|
D015054 |
Zymosan |
Zymosan results in decreased expression of PPARGC1A mRNA | decreases expression | 16061943
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.86 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
10.41 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
10.41 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
10.41 | 11752688 14514962 15322242 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
4.26 | 10992263 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.25 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.25 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.26 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
6.98 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
6.98 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
Turpentine |
5.50 | 16044259 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
5.73 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
5.73 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
5.73 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
5.38 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
5.38 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
13.42 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
13.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
13.42 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.01 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.22 | 17306315 16712894 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.63 | 15451040 15451039 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.07 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
7.87 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
icariin |
7.87 | 19858766 19782061 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
7.87 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
7.87 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
11.63 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
11.63 | 16960172 |
MESH:D000740 |
Anemia |
|
Zymosan |
11.63 | 18664788 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.63 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
4.21 | 16960172 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
9.99 | 10982225 |
MESH:D000799 |
Angioedema |
|
salmeterol |
9.99 | 10982225 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.16 | 15513904 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.17 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.46 | 11141031 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.42 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
8.52 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.52 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
13.92 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
13.92 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
13.92 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
13.92 | 15944321 15188379 17659584 15142272 16872482 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.07 | 16292516 |
MESH:D001249 |
Asthma |
|
Albuterol |
9.30 | 9949315 11991558 |
MESH:D001249 |
Asthma |
|
salmeterol |
9.30 | 10359889 11694805 |
MESH:D001249 |
Asthma |
|
Tretinoin |
9.30 | 16456186 |
MESH:D001249 |
Asthma |
|
Vitamin A |
9.30 | 16732791 |
MESH:D001250 |
Asthma, Exercise-Induced |
|
salmeterol |
5.44 | 10984370 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.30 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
2.85 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.34 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
2.34 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
Propranolol |
2.34 | 18766980 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.75 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.76 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.00 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.00 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.00 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.00 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 |
MESH:D001847 |
Bone Diseases |
|
icariin |
5.73 | 18295595 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.30 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Isoproterenol |
9.11 | 6740701 |
MESH:D001919 |
Bradycardia |
|
Propranolol |
9.11 | 6740701 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.65 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Nitroprusside |
9.24 | 14637104 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
9.24 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
icariin |
8.52 | 19303870 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
8.52 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
9.55 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
9.55 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
9.55 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
9.55 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
9.55 | 12948864 17289903 16675129 19861407 17261762 18497071 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
9.55 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
9.55 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
9.55 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
9.55 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
9.55 | 19410462 19155303 16273361 16818667 20390343 17893378 20859285 18821012 19288272 11161223 21152245 18351453 15668708 19011961 19487384 19059307 20005174 18815881 18425577 19244106 21138602 17242785 19084267 18629630 19289846 20065188 17440819 20135344 17049068 18855134 17261762 19221464 19103187 19189210 19200415 19142967 18984771 15565566 16873071 19066611 19115204 19189212 20544844 16202921 18997820 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
9.55 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
9.55 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
9.55 | 16873071 16443354 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
4.35 | 12794006 |
MESH:D029481 |
Bronchitis, Chronic |
|
salmeterol |
5.86 | 17687719 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
10.79 | 16813970 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
10.79 | 17426644 17377406 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.70 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
4.00 | 16374292 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.86 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.79 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.26 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.85 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.47 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
25.19 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
25.19 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
25.19 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
25.19 | 14691202 15553829 16217749 15073043 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
25.19 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
25.19 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
25.19 | 17173139 1701930 20007298 20935162 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
25.19 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
25.19 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
25.19 | 15276417 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
25.19 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
25.19 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.92 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.30 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.19 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.52 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
11.60 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
11.60 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
11.60 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
11.60 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
11.60 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.03 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
17.10 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Isoproterenol |
17.10 | 11179087 7544033 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
17.10 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
17.10 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
17.10 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Aldosterone |
9.73 | 11230374 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
9.73 | 16756079 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
9.73 | 15458977 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
4.87 | 8216760 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.78 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.78 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.01 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.01 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
12.01 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.01 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.60 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.92 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.39 | 20678186 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
4.79 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.59 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
10.54 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
10.54 | 19176532 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
10.54 | 16175620 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.47 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.19 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
11.37 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
11.37 | 15668235 8697196 15340226 12621046 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
11.37 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
11.37 | 16054864 |
MESH:D003092 |
Colitis |
|
Carbon Monoxide |
12.52 | 16365149 |
MESH:D003092 |
Colitis |
|
resveratrol |
12.52 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
12.52 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
6.89 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
6.89 | 15741050 17191121 11134977 19056647 17148506 16640504 19440933 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
6.89 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
6.89 | 17219422 16267017 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.02 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.02 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.02 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.49 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
7.23 | 18504504 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
7.23 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.55 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
8.00 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
8.00 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
8.00 | 15451040 11198716 15513904 19302082 10194807 11873399 15451039 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
8.00 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
8.00 | 10589399 16925845 17551590 9224671 8800419 9664655 9125849 9211117 9142499 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
8.00 | 10992263 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.36 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.47 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.71 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.80 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.07 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
3.73 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
10.89 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
10.89 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
10.89 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.26 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
8.51 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
8.51 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
8.51 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
troglitazone |
8.51 | 16023994 |
MESH:D003925 |
Diabetic Angiopathies |
|
troglitazone |
4.98 | 12601628 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
11.71 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
11.71 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
11.71 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.84 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.08 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
14.68 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.68 | 16081117 10663392 19164858 19416960 19085960 11739529 15968718 17562736 2444490 12153990 17522070 10774834 16177239 18713872 19923254 11529661 17906064 14725611 15619225 19370779 18071297 11743745 12705907 16393943 12958197 16781746 14986274 14550746 10915739 12540782 16109766 19739265 16227642 16485898 11287661 12392966 19420014 11461765 11421492 11834606 12594235 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
14.68 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
14.68 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
14.68 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.68 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
troglitazone |
14.68 | 14986274 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.41 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.25 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
5.13 | 16146918 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.95 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Albuterol |
5.14 | 20016425 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.38 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
4.93 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
5.14 | 16054864 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.82 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
19.33 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
19.33 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
19.33 | 8985016 |
MESH:D004487 |
Edema |
|
rosiglitazone |
19.33 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
19.33 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Zymosan |
19.33 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.67 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.67 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
22.05 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
ciglitazone |
22.05 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
22.05 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
22.05 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
22.05 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
13.96 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
13.96 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
13.96 | 17893378 20544844 16202921 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
13.96 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
6.97 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
6.97 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.73 | 15821434 17637181 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.19 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.45 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.19 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
5.86 | 821787 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
5.86 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.97 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.35 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
icariin |
4.79 | 16281085 15329286 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
5.95 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
5.95 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
5.95 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.10 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.10 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
32.79 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
32.79 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
32.79 | 18296743 19004024 17967931 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
32.79 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
32.79 | 18395287 19196556 18641190 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
32.79 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
32.79 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
32.79 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
4.98 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.79 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.63 | 10194807 16946407 15451040 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.80 | 11858732 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
4.68 | 16054864 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.43 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.86 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.51 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Albuterol |
31.53 | 15467267 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
31.53 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
31.53 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
31.53 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
31.53 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
31.53 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
31.53 | 17994277 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.17 | 7506515 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.62 | 16904648 |
MESH:D005739 |
Gas Poisoning |
|
Albuterol |
5.52 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
8.86 | 16983495 |
MESH:D005756 |
Gastritis |
|
Ethanol |
8.86 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.01 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.55 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
9.32 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
9.32 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
9.32 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.75 | 17643826 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.70 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.91 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.71 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.47 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
12.72 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
12.72 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
12.72 | 14991402 9664655 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
12.72 | 10992263 16080930 |
MESH:D006333 |
Heart Failure |
marker/mechanism |
|
| 19808358 |
MESH:D006333 |
Heart Failure |
|
Isoproterenol |
9.53 | 18097624 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
9.53 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Propranolol |
9.53 | 20082655 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.75 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.79 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.73 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.07 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
15.41 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.41 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Propranolol |
15.41 | 16371745 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.41 | 12621046 16120746 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
5.34 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
5.34 | 16863852 16490937 16877224 16292552 17436238 15707848 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.35 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.52 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
4.97 | 17019078 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
3.44 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
4.93 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.60 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.07 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
18.79 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
18.79 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
18.79 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
18.79 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
18.79 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.62 | 17019078 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
12.05 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
12.05 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
12.05 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.91 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
12.40 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
12.40 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
12.40 | 11834736 18262572 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.33 | 19008412 18360027 14757778 15752949 18563319 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
12.01 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
12.01 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
12.01 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
13.08 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
13.08 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
13.08 | 19008412 14633139 14568997 16843071 14573337 |
MESH:D006973 |
Hypertension |
|
Quercetin |
13.08 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
13.08 | 18850075 18670907 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.49 | 19342510 19799862 |
MESH:D006984 |
Hypertrophy |
|
Isoproterenol |
4.59 | 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.71 | 17488730 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
5.48 | 16054864 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.09 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.52 | 17426086 |
MESH:D007022 |
Hypotension |
|
Isoproterenol |
12.09 | 6740701 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
12.09 | 6740701 |
MESH:D007022 |
Hypotension |
|
Propranolol |
12.09 | 6740701 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.17 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
9.31 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
9.31 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.53 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
25.32 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
25.32 | 20412841 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
25.32 | 12878042 17237260 9205823 17255318 17963957 |
MESH:D007249 |
Inflammation |
|
Progesterone |
25.32 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
25.32 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
25.32 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
25.32 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
25.32 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Zymosan |
25.32 | 11289658 8014878 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
8.93 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
8.93 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
18.24 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
18.24 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
18.24 | 18981581 19799862 19586609 17133782 18563319 18057795 19008412 14757778 14633139 19342510 14573337 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
18.24 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
18.24 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.12 | 17994277 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
5.14 | 15955940 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.01 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.16 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
13.68 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
13.68 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
13.68 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.30 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.76 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
4.96 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.52 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.52 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.52 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
14.52 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.52 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.20 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.20 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.20 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
13.20 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
8.08 | 15451040 |
MESH:D007859 |
Learning Disorders |
|
icariin |
8.08 | 19782061 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
15.67 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
15.67 | 15070760 |
MESH:D007938 |
Leukemia |
|
kaempferol |
15.67 | 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
15.67 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
15.67 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
troglitazone |
5.46 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.19 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.64 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.91 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
7.46 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.46 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.32 | 16467208 20471514 16968895 17050201 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.32 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
10.05 | 11161223 17107899 16966277 17712046 16330433 19642359 16891316 16112521 15748426 17649720 15213294 16823087 19075265 12018890 19225113 19035177 15622746 12712474 16331271 9834237 15336539 17217047 17869043 11468182 12679006 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.05 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
10.05 | 16823087 17217047 17294898 19075265 16766008 17301526 17649720 16891316 17368321 16140955 19035177 17361223 19642359 17506722 16331271 16935935 15748426 19225113 17712046 12679006 16788101 19029980 17107899 17339181 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.71 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.03 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
10.91 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
10.91 | 9224671 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
10.91 | 16054864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.66 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
12.43 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
12.43 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
12.43 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
12.43 | 16256175 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.42 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
17.80 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
17.80 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
17.80 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
17.80 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
17.80 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
17.80 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
17.80 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
17.80 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
17.80 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
17.80 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
17.80 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
7.59 | 12969438 11587558 16611625 19014921 19784758 19460945 16610002 12587719 |
MESH:D008107 |
Liver Diseases |
|
Carbon Monoxide |
7.59 | 17173083 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
7.59 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
7.59 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
9.37 | 17347304 17207112 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
9.37 | 16762690 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.65 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
35.03 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
35.03 | 9163691 2125692 15890375 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
35.03 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
35.03 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
35.03 | 8742319 21047994 19073162 15975961 19482888 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
35.03 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
35.03 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
35.03 | 20405173 19073162 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
35.03 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
35.03 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
35.03 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
XCT790 |
35.03 | 19464277 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
21.34 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
21.34 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
21.34 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
21.34 | 17172636 2563599 18308698 6150874 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
21.34 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
21.34 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
21.34 | 17113696 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.83 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.18 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
6.18 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
7.14 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
7.14 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
15.13 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
15.13 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
15.13 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
15.13 | 20869020 18569708 6695378 17053015 18816296 18520028 20135361 20464547 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
ciglitazone |
15.13 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
15.13 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
15.13 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
15.13 | 15276417 17306315 17077188 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
15.13 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
15.13 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Rifampin |
5.46 | 11422169 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Rifampin |
3.74 | 11422169 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.68 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.32 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.78 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.78 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.94 | 16891317 17203775 11807958 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
13.94 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
13.94 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
13.94 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
13.94 | 11731420 16827153 19196722 19196723 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.37 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.37 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.47 | 17453147 |
MESH:D008545 |
Melanoma |
|
Glucose |
7.98 | 14993021 |
MESH:D008545 |
Melanoma |
|
resveratrol |
7.98 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.98 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.98 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.98 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.51 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.91 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
8.06 | 15451040 18411066 |
MESH:D008569 |
Memory Disorders |
|
icariin |
8.06 | 19782061 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.77 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
2.87 | 16166281 16966607 18303189 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.77 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
8.17 | 17098227 18497449 19165636 17261469 16815490 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
8.17 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.10 | 16801185 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
4.52 | 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.66 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
13.22 | 15949261 11468182 14977855 19549372 19417148 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
13.22 | 15867202 16118317 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
13.22 | 16490592 17049120 17935668 17164350 16267019 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
13.22 | 16374440 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.59 | 18160304 10479408 12879239 12130978 15241586 10890648 15259001 17724436 15834315 15213630 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.20 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
Bezafibrate |
14.26 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
GW 501516 |
14.26 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
14.26 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
Rifampin |
4.87 | 18474467 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.99 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
9.89 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
9.89 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.89 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Isoproterenol |
10.86 | 15740881 16697266 19172585 17052832 19595682 16538859 16584858 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
10.86 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
10.86 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
10.86 | 16525036 16456233 17188708 17015251 17125593 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.19 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.19 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.00 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
16.00 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.00 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.00 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.09 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.80 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.19 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.32 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.24 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.25 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
14.85 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.85 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.85 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
14.85 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.85 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.85 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.07 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.07 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.32 | 19196722 19200415 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.07 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.71 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
12.65 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
12.65 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
12.65 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
13.53 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
13.53 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
13.53 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
13.53 | 17400914 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
6.50 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.50 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.63 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.63 | 17929310 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.21 | 21332399 20132043 16723640 19632207 18457598 18674790 17217161 11836018 20518802 |
MESH:D009765 |
Obesity |
|
Fructose |
6.21 | 17707055 18585860 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.21 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
2.85 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.69 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
icariin |
6.69 | 18236786 19747809 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
6.69 | 16756079 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.14 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.14 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
18.78 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
18.78 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
18.78 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
18.78 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
18.78 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
18.78 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
18.78 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
4.78 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
4.78 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
13.14 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
13.14 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
13.14 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
13.14 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
13.14 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.54 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
3.89 | 19014385 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.56 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.23 | 14761945 18977430 15979727 17826846 18557954 19641140 19088179 18760300 17371808 11985352 15259001 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.24 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
3.89 | 12224865 11605937 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.32 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.92 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
12.01 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
12.01 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
12.01 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.13 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
7.38 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.38 | 11896295 11118676 11399792 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.11 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.85 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
8.85 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
2.59 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.59 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.59 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.59 | 12479363 15754350 16289102 18247401 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.59 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.59 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.59 | 16731767 17675339 15767336 17804756 17718901 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.59 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.59 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
2.99 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
3.81 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.95 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.12 | 16723453 |
MESH:D011654 |
Pulmonary Edema |
|
Isoproterenol |
4.57 | 10903255 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
5.23 | 17365031 15814490 17975199 17322281 |
MESH:D011658 |
Pulmonary Fibrosis |
|
troglitazone |
5.23 | 18162602 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.90 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.31 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.31 | 16317513 16314181 17058453 17520802 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.40 | 18379247 11700416 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
5.13 | 16877224 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.26 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.48 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.57 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.32 | 16646077 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.86 | 16862918 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
7.12 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
7.12 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
7.12 | 3137016 11442880 4039156 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.15 | 6407741 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.09 | 11441115 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.52 | 16631401 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
3.15 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
21.59 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
21.59 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
21.59 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
21.59 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
21.59 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
21.59 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.59 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.61 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
8.65 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
8.65 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.26 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.66 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
5.34 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
5.34 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
5.34 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
5.34 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
troglitazone |
5.34 | 15930296 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
5.59 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
5.59 | 9562338 11906479 9211565 17918041 17189318 16755016 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.89 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.67 | 9754883 |
MESH:D013610 |
Tachycardia |
|
Nitroprusside |
9.48 | 15306635 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
9.48 | 3261545 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
4.15 | 6499806 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.58 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.22 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
12.88 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
12.88 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
12.88 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.88 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.00 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
7.95 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.95 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.29 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Rifampin |
6.92 | 18397238 15236969 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
6.92 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.72 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.72 | 20435036 12845720 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
15.72 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
15.72 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
15.72 | 11723127 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.72 | 17572228 8653321 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.65 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
7.21 | 10982225 |
MESH:D014581 |
Urticaria |
|
salmeterol |
7.21 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
12.49 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
12.49 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
12.49 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.50 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.93 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
16.36 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
16.36 | 1336536 |
MESH:D014605 |
Uveitis |
|
Zymosan |
16.36 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.75 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.91 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Isoproterenol |
8.50 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.50 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
Isoproterenol |
5.02 | 18097624 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
4.65 | 16960172 16175781 16146918 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.42 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.56 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.16 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.39 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.76 | 17120751 |